跳至主要内容
临床试验/NCT05505565
NCT05505565已完成不适用

Continuous Glucose Monitors in the Management of Youth With Prediabetes

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2023年6月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
1
主要终点
CGM Acceptability

研究概览

简要总结

We are evaluating whether intermittent use of continuous glucose monitors (CGMs) in addition to standard nutritional counseling and physical activity counseling is associated with improved metabolic health for youth with pre-diabetes (PD).

详细描述

The purpose of this research study is to test if CGMs are tolerable to youth with pre-diabetes (PD) and their caregivers. We are also evaluating if CGMs add benefit to standard treatment in youth with prediabetes. The CGM in question, Abbott Freestyle Libre 2 is approved by the Food and Drug Administration (FDA) to treat patients aged 4 and up with diabetes. We want to determine if this CGM may benefit people who have PD. People who enter the study will either receive standard medical care for prediabetes or receive standard medical care for prediabetes plus use a CGM for 2 weeks each month to receive real-time biofeedback on their glucose levels during the day.

There will be 3 visits over a 6-month period, baseline, 3-month, and 6-month visits. At each visit fasting labs will be obtained including: complete metabolic panel, lipid panel, pro-insulin, c-peptide, insulin. Anthropomorphics including body mass index, waist circumference, and hip circumference will be monitored.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
11 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 11 or older
  • •English-speaking
  • •stable metformin dose for 1 month prior to enrollment or no metformin use
  • •baseline A1c of 5.7-6.4%
  • •BMI > = 85% for age

排除标准

  • •BMI < 85% for age
  • •chronic steroid use
  • •diagnosis of type 1 diabetes, type 2 diabetes, other forms of diabetes
  • •current or history of malignancy

研究组 & 干预措施

CGM + Traditional Counseling

Experimental

Subjects in this arm will receive intermittent CGM to be used for 2-weeks each month for the 6-month study period. They will be required to wear a CGM during baseline, 3-month, and 6-month periods. Additional CGM sensors will be supplied for months 1, 2, 4, and 5 and will be optional. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.

干预措施: Abbott Freestyle Libre 2 (Device)

CGM + Traditional Counseling

Experimental

Subjects in this arm will receive intermittent CGM to be used for 2-weeks each month for the 6-month study period. They will be required to wear a CGM during baseline, 3-month, and 6-month periods. Additional CGM sensors will be supplied for months 1, 2, 4, and 5 and will be optional. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.

干预措施: Standard physical activity and nutritional counseling for prediabetes management (Other)

Caregivers of CGM + Traditional Counseling Group

No Intervention

Caregivers of those randomized to the intervention group were enrolled to give their feedback on the continuous glucose monitor via surveys at the 3-month and 6-month visits. Outside these surveys, there were no other inputs or interventions to this group.

Control

Active Comparator

Subjects in this arm will receive standard medical care for pre-diabetes. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.

干预措施: Standard physical activity and nutritional counseling for prediabetes management (Other)

结局指标

主要结局

CGM Acceptability

时间窗: 6 months

Caregiver and patient acceptability of CGM use

Change in Measured % HbA1c From Baseline to 6-months

时间窗: 6 months

The difference in measured percentage of glycosylated hemoglobin (hemoglobin A1c) was obtained by subtracting the 6-month value from the baseline value for all subjects with paired data available. A negative result indicates a reduction (improvement) in hemoglobin A1c over the period.

次要结局

  • Change in HOMA-IR From Baseline to 6-months.(6 months)
  • Change in Triglyceride, HDL, LDL, and Total Cholesterol From Baseline to 6-month(6 months)
  • Changes in Liver Enzymes From Baseline to 6-months.(6 months)
  • Glycemic Metrics(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jessica Schmitt

Assistant Professor

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验